Generics manufacturer prioritizes cardiac drugs amid shortages fears
Medivant to prioritize manufacturing of four generic drugs for cardiac diseases, amid fears of drug shortages due to COVID-19.
Archives for March 23, 2020
EMA calls to scale up COVID-19 trials for conclusive data
The agency says the industry should prioritize large randomized controlled studies developing COVID-19 treatments, to acquire robust data.
Trial management service available for free amid COVID-19 pandemic
Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.
TrialJectory matches cancer patients, clinical trials
The AI-assisted platform, created by a cancer survivor, connects oncology patients with care options in an online marketplace.
Industry ups chloroquine production, donates millions of doses
Manufacturers of hydroxychloroquine are increasing production and a number have offered to donate doses to combat COVID-19.
Eli Lilly shifts clinical trial activity during coronavirus
The pharmaceutical company has announced several changes to its clinical trial activities in the face of the global pandemic.